CTC
HAE icon

Cetera Trust Company’s Haemonetics HAE Stock Holding History

Cetera Trust Company’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$251K Hold
4,450
– – 0.14% 134
2025
Q4 		$357K Buy
4,450
+75
+2% +$5.04K 0.19% 91
2025
Q3 		$213K Buy
+4,375
New +$271K 0.12% 159

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cetera Trust Company's HAE Position: Q1 2026 in Review

Cetera Trust Company held its Haemonetics (HAE) position steady in Q1 2026 at 4,450 shares worth $251K. The position accounts for 0.14% of the portfolio, ranked #134.

Cetera Trust Company first reported a position in HAE in Q3 2025 and has held it in 3 quarters since. The position peaked at $357K in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Cetera Trust Company held 4,450 shares of Haemonetics worth $251K as of Q1 2026.
  • Cetera Trust Company left its Haemonetics share count unchanged in Q1 2026.
  • Haemonetics made up 0.14% of Cetera Trust Company's portfolio in Q1 2026, its #134 holding.
  • Cetera Trust Company first reported a position in Haemonetics in Q3 2025 and has held it in 3 quarters since.
  • Cetera Trust Company's Haemonetics position peaked at $357K in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.